SGK269 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.887400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.909200E-01
Normal-vs-Stage2
3.999800E-01
Normal-vs-Stage3
3.036800E-01
Normal-vs-Stage4
5.123000E-01
Stage1-vs-Stage2
8.580600E-01
Stage1-vs-Stage3
2.938400E-01
Stage1-vs-Stage4
2.840200E-01
Stage2-vs-Stage3
2.731600E-01
Stage2-vs-Stage4
1.823970E-01
Stage3-vs-Stage4
1.208010E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.853600E-01
Normal-vs-AfricanAmerican
2.857000E-01
Normal-vs-Asian
3.450200E-01
Caucasian-vs-AfricanAmerican
3.735400E-01
Caucasian-vs-Asian
4.261000E-01
AfricanAmerican-vs-Asian
2.679800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.818400E-01
Normal-vs-Female
3.989200E-01
Male-vs-Female
5.732200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.021000E-01
Normal-vs-Age(41-60Yrs)
4.503000E-01
Normal-vs-Age(61-80Yrs)
3.700000E-01
Normal-vs-Age(81-100Yrs)
3.252400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.042600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.514200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.368000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.413700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.641600E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.754600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.652000E-01
Normal-vs-Daily Drinker
3.063000E-01
Normal-vs-Weekly Drinker
4.075200E-01
Normal-vs-Occasional Drinker
3.535200E-01
Normal-vs-Social Drinker
1.790650E-01
Non Drinker-vs-Daily Drinker
1.521790E-01
Non Drinker-vs-Weekly Drinker
5.068600E-01
Non Drinker-vs-Occasional Drinker
8.003800E-01
Non Drinker-vs-Social Drinker
2.380200E-01
Daily Drinker-vs-Weekly Drinker
6.409700E-02
Daily Drinker-vs-Occasional Drinker
2.764600E-01
Daily Drinker-vs-Social Drinker
5.093900E-02
Weekly Drinker-vs-Occasional Drinker
4.069800E-01
Weekly Drinker-vs-Social Drinker
5.223200E-01
Occasional Drinker-vs-Social Drinker
1.951810E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.207800E-01
Normal-vs-Grade 2
2.795600E-01
Normal-vs-Grade 3
3.560400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.754260E-02
Grade 1-vs-Grade 3
7.694400E-02
Grade 1-vs-Grade 4
7.207800E-01
Grade 2-vs-Grade 3
6.812400E-01
Grade 2-vs-Grade 4
2.795600E-01
Grade 3-vs-Grade 4
3.560400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.866000E-01
Normal-vs-NonDiabetic
3.685600E-01
Diabetic-vs-NonDiabetic
6.385800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.938600E-01
Normal-vs-NoPancreatitis
3.762800E-01
Pancreatitis-vs-NoPancreatitis
7.911000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.639000E-01
Normal-vs-N1
4.047000E-01
N0-vs-N1
2.069800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.093600E-01
Normal-vs-TP53-NonMutant
3.416800E-01
TP53-Mutant-vs-TP53-NonMutant
4.225600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
